High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis

被引:0
|
作者
Adil Maarouf
Delphine Stephan
Marie-Pierre Ranjeva
Jean-Philippe Ranjeva
Jean Pelletier
Bertrand Audoin
Michel Khrestchatisky
Sophie Desplat-Jégo
机构
[1] Aix-Marseille Univ,
[2] CNRS,undefined
[3] CRMBM,undefined
[4] Assistance Publique-Hôpitaux de Marseille,undefined
[5] Hôpital de la Timone,undefined
[6] CEMEREM,undefined
[7] Assistance Publique-Hôpitaux de Marseille,undefined
[8] Hôpital de la Timone,undefined
[9] Pôle de Neurosciences Cliniques,undefined
[10] Service de Neurologie,undefined
[11] Aix-Marseille Université,undefined
[12] CNRS,undefined
[13] Faculté de Médecine,undefined
[14] Institut de NeuroPhysiopathologie (INP),undefined
[15] Inst Neurophysiopathol,undefined
[16] Assistance Publique-Hôpitaux de Marseille,undefined
[17] Hôpital de la Conception,undefined
[18] Pôle de Biologie,undefined
[19] Service d’Immunologie,undefined
来源
Journal of Translational Medicine | / 17卷
关键词
TWEAK; Multiple sclerosis; Neuroinflammation; Biomarker; Cytokine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] The increased serum level of sRAGE is associated with multiple sclerosis but not with disability progression
    Cierny, Daniel
    Michalik, Jozef
    Hanysova, Sandra
    Kantorova, Ema
    Skerenova, Maria
    Kurca, Egon
    Dobrota, Dusan
    Lehotsky, Jan
    NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY, 2018, 35 (02): : 70 - 76
  • [42] Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation
    Morandi, Fabio
    Venturi, Consuelo
    Rizzo, Roberta
    Castellazzi, Massimiliano
    Baldi, Eleonora
    Caniatti, Maria Luisa
    Tola, Maria Rosaria
    Granieri, Enrico
    Fainardi, Enrico
    Uccelli, Antonio
    Pistoia, Vito
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (04) : 944 - 955
  • [43] Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation
    Fabio Morandi
    Consuelo Venturi
    Roberta Rizzo
    Massimiliano Castellazzi
    Eleonora Baldi
    Maria Luisa Caniatti
    Maria Rosaria Tola
    Enrico Granieri
    Enrico Fainardi
    Antonio Uccelli
    Vito Pistoia
    Journal of Neuroimmune Pharmacology, 2013, 8 : 944 - 955
  • [44] Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis
    Bsteh, Gabriel
    Berek, Klaus
    Hegen, Harald
    Buchmann, Arabella
    Voortman, Margarete M.
    Auer, Michael
    Wurth, Sebastian
    Zinganell, Anne
    Di Pauli, Franziska
    Deisenhammer, Florian
    Khalil, Micheal
    Berger, Thomas
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [45] Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions
    Losy, J
    Niezgoda, A
    Wender, M
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 99 (02) : 169 - 172
  • [46] High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels
    Toncev, G
    Milicic, B
    Toncev, S
    Samardzic, G
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (05) : 505 - 508
  • [47] Raised serum nitrate and nitrite levels in patients with multiple sclerosis
    Giovannoni, G
    Heales, SJR
    Silver, NC
    ORiordan, J
    Miller, RF
    Land, JM
    Clark, JB
    Thompson, EJ
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 145 (01) : 77 - 81
  • [48] Serum interleukin-12 levels in patients with multiple sclerosis
    Drulovic, J
    Mostarica-Stojkovic, M
    Levic, Z
    Mesaros, S
    Stojsavljevic, N
    Popadic, D
    Pravica, V
    NEUROSCIENCE LETTERS, 1998, 251 (02) : 129 - 132
  • [49] Serum vitamin D levels in Indian patients with multiple sclerosis
    Suresh Kumar R.
    Syed S.
    Anand Kumar A.
    Subha Kumari K.N.
    Sajitha K.
    Indian Journal of Clinical Biochemistry, 2013, 28 (3) : 255 - 258
  • [50] Serum sAPO-1/Fas levels in multiple sclerosis
    Bansil, S
    Holtz, CR
    Cook, SD
    RohowskyKochan, C
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (04): : 208 - 210